Zyme Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Zyme's estimated annual revenue is currently $27.4M per year.(i)
  • Zyme's estimated revenue per employee is $154,000

Employee Data

  • Zyme has 178 Employees.(i)
  • Zyme grew their employee count by -8% last year.

Zyme's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Area VP Customer SolutionsReveal Email/Phone
3
Group VP, Product StrategyReveal Email/Phone
4
Chief Accounting Officer (CAO)Reveal Email/Phone
5
Group VP Information Security & ComplianceReveal Email/Phone
6
Area VP, Finance - Global Business UnitReveal Email/Phone
7
Area VP, Professional ServicesReveal Email/Phone
8
Associate VP, Product DevelopmentReveal Email/Phone
9
Area VP, Data Marketplace Sales and OperationsReveal Email/Phone
10
Area VPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M14-12%N/AN/A
Add Company

What Is Zyme?

Zyme, now part of E2open, provides the leading channel data management (CDM) cloud platform, delivering critical downstream visibility for global companies that leverage distributors, resellers, retailers and e-tailers to sell their products. Zyme's flexible, real-time data platform powers the New Smart Channelâ„ , a proven approach to acquiring actionable knowledge that enterprises need to accelerate partner sales and optimize marketing ROI. With a channel directory of more than 2 million partners, Zyme processes more than 1 billion transactions annually across more than 150 countries, providing decision-grade intelligence to optimize business processes like sales execution, inventory management, partner rebates and incentives, marketing and financial compliance. Pre-built integrations with Salesforce and other innovative cloud solution providers help Zyme's industry-leading customers, including Amazon, Dell, Fujitsu, GE, Microsoft, Plantronics, Seagate, Symantec, VMware and Xerox use channel intelligence to solve core business problems. For more information, visit www.e2open.com

keywords:N/A

N/A

Total Funding

178

Number of Employees

$27.4M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zyme News

2022-04-20 - Zymeworks (ZYME) Stock: Why The Price Surged Over 30%

(NYSE: ZYME) – a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics – increased by over 30% pre...

2022-04-20 - All Blue Capital in $773 mln bid for Zymeworks

April 28 (Reuters) - Investment firm All Blue Capital has approached Zymeworks Inc (ZYME.N), a developer of antibody therapies for cancer,...

2022-04-20 - Zymeworks Shares Surge Premarket on $773 Million Buyout Proposal ZYME

Zymeworks Shares Surge Premarket on $773 Million Buyout Proposal ZYME. Published: April 29, 2022 at 6:05 a.m. ET. comments...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$52.9M1789%N/A
#2
$28.4M17816%N/A
#3
$53.2M1795%N/A
#4
$53.2M179-3%N/A
#5
N/A17925%N/A